Axcella Therapeutics (AXLA)

3Q22 Reported After An Eventful Quarter


Robert LeBoyerMedia Inquiries
Senior Life Sciences Analyst
November 2, 2022
Report ID: 25330
Get Report
Refer to the full report for the price target, fundamental analysis, and rating.

Equity Research provided by Noble Capital Markets is available at no cost to Registered users of Channelchek.

Already Registered? Click the ‘Get Report’ button to login and view the research report.

Not a Member? Click ‘Join’ or ‘Get Report’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.


Axcella Therapeutics
Axcella Therapeutics
Healthcare
Biotechnology
Ticker
AXLA
Current Price
$0.4009
Market Cap
$1.2M
Price Target
Refer to Report
Volume
7.0K
52wk Range
$0.34 - $41.25
Related Research Reports
9/20/2023

Dropping Coverage
Dropping Coverage (AXLA)
3/31/2023

FY2022 Reported With AXA1125 “Phase 2b/3 Ready”
FY2022 Reported With AXA1125 “Phase 2b/3 Ready” (AXLA)
2/17/2023

Regulatory Pathway Clarified for AXA1125
Regulatory Pathway Clarified for AXA1125 (AXLA)
2/16/2023

Phase 2b/3 Trial Receives Clearance To Move Forward
Phase 2b/3 Trial Receives Clearance To Move Forward (AXLA)

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2024 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.